Blood-Based Biomarkers of Systemic Inflammation, Metabolic Function, and Vascular Injury Distinguish Patients with Rapid and Typical Progressive Neurodegenerative Diseases (P9-3.020)
Evaluate the ability of blood-based biomarkers of systemic inflammation, metabolic function, and vascular injury to distinguish patients with rapid and typical progressive Alzheimer disease and related dementias (AD/ADRD).
Authors
- Philip W. Tipton (ORCID: https://orcid.org/0000-0003-4084-2248)
- Nihal Satyadev (ORCID: https://orcid.org/0000-0001-7302-2348)
- Matthew R. Brier (ORCID: https://orcid.org/0000-0001-5987-8705)
- Lindsey A. Kuchenbecker (ORCID: https://orcid.org/0000-0002-2987-1040)
- Gregory Day
- Steven Dunham (ORCID: https://orcid.org/0000-0003-2840-3955)
- Yoav D. Piura (ORCID: https://orcid.org/0000-0003-1004-4560)
- Sid E. O’Bryant (ORCID: https://orcid.org/0000-0003-0582-5266)
- Neill R. Graff‐Radford (ORCID: https://orcid.org/0000-0001-9847-9096)
Institutions
- University of North Texas (US)
- University of North Texas Health Science Center (US)
- Mayo Clinic in Florida (US)
- Neurology, Inc (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000209025
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00